Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Cough reduction using cap… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




Cough reduction using capsaicin

Artikel i vetenskaplig tidskrift
Författare Ewa Ternesten-Hasséus
Ewa-Lena Johansson
Eva Millqvist
Publicerad i Respiratory Medicine
Volym 109
Nummer/häfte 1
Sidor 27-37
ISSN 0954-6111
Publiceringsår 2015
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering
Institutionen för medicin
Sidor 27-37
Språk en
Länkar dx.doi.org/10.1016/j.rmed.2014.11.0...
Ämnesord Capsaicin, Chronic cough, Desensitization, Sensory hyperreactivity, AIRWAY SENSORY HYPERREACTIVITY, ASTHMA-LIKE SYMPTOMS, INHALED CAPSAICIN, TRP CHANNELS, VANILLOID RECEPTOR, HYPERSENSITIVITY, SENSITIVITY, DYSFUNCTION, PREVALENCE, MECHANISMS, Cardiac & Cardiovascular Systems, Respiratory System, ERK PJ, 1993, EUROPEAN RESPIRATORY JOURNAL, V6, P53, OUDRY NB, 1992, EUROPEAN RESPIRATORY JOURNAL, V5, P296
Ämneskategorier Klinisk medicin

Sammanfattning

Chronic unexplained cough triggered by environmental irritants is characterized by increased cough reflex sensitivity, which can be demonstrated by means of inhaled capsaicin. Topical capsaicin can be used to improve non-allergic rhinitis and intestinal hypersensitivity and to reduce neuropathic pain. Objectives: We established whether an oral intake of natural capsaicin (chilli) could desensitize the cough reflex and improve unexplained coughing. Methods: Twenty-four patients with irritant-induced, unexplained chronic cough and 15 controls were included in the study. For 4 weeks, the participants took capsules with pure capsaicin, and for 4 weeks, they took placebo capsules. The protocol was crossover, randomized, and double blind. Cough sensitivity during the study was evaluated by a standardized capsaicin inhalation cough test that assessed the capsaicin concentration required to reach two coughs (C2) and five coughs (C5). Participants were also administered questionnaires on cough and cough-related symptoms. Results: Three patients withdrew before the study end, one during the active treatment period and two during the placebo period. After treatment with capsaicin, the thresholds for C2 were higher (improved) both in patients (p < 0.020) and in controls (p < 0.0061) compared to after the placebo period. Among patients, the concentration needed to reach C2 (p < 0.0004) and C5 (p < 0.0009) increased after the period with the active substance compared to cough thresholds at baseline. The cough symptom scores improved after 4 weeks of active treatment (p < 0.0030) compared to the baseline scores. Conclusion: Capsaicin powder taken orally decreased capsaicin cough sensitivity and cough symptoms. The findings suggest a desensitization of the cough-sensitive transient receptor potential vanilloid-1 (TRPV1). (C) 2014 The Authors. Published by Elsevier Ltd.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?